Cover of Off-label drug use and FDA review of supplemental drug applications

Off-label drug use and FDA review of supplemental drug applications

by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

1997 152 pages eng

Read online

Reader not loading? Open it on Archive.org instead.